Menu Menu

VRTX    Vertex Pharmaceuticals Inc Ma    875320    
Income Statement
Revenue 2,771,900,000
Net Income 1,045,400,000
Profit Margin 37.71%

Balance Sheet
Current Assets 9,804,100,000
Assets 22,240,200,000
Current Liabilities 3,973,100,000
Liabilities 6,609,300,000
Equity 15,630,900,000
Shares Out 258,102,000

Cash Flow Statement
Operating Cash Flow -1,077,200,000
Investing Cash Flow -2,948,100,000

Market Analysis
Market Cap 124,258,140,255
Price 422.00
BVPS 60.56
PB 6.97
EPS -2.02
PS 11.21
FCF -4,025,300,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/05 4.20
Apr May Jun
5/06 4.76
Jul Aug Sep
8/01 -12.83
Oct Nov Dec
11/5 4.05

Find a discrepancy? The most accurate way to find company fundamental data is to view VRTX documents filed with the SEC.


VRTX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: